Biametrics, a four-year-old German technology company, is in the midst of introducing two new products that support label-free, kinetic microarray experiments.

The first, called B-screen, enables the characterization of biomolecular interactions in bioanalytics and drug discovery, as well as array production and quality control, according to the firm. By combining B-screen with standard microarrays users can obtain a label-free readout of kinetic data for up to 10,000 spots per square centimeter, the company said in a statement last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.